NanoViricides
NNVC
#10132
Rank
C$30.58 M
Marketcap
C$1.70
Share price
0.82%
Change (1 day)
-16.99%
Change (1 year)

NanoViricides (NNVC) - Net assets

Net assets on the balance sheet as of June 2025 : C$10.38 Million

According to NanoViricides's latest financial reports the company has C$10.38 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

NanoViricides - Net assets on balance sheet (from 2006 to 2025)

Net assets by year

Year Net assets Change
2024-06-30$C$15.67 M-20.33%
2023-06-30$C$19.67 M-33.79%
2022-06-30$C$29.71 M-19.84%
2021-06-30$C$37.06 M25.51%
2020-06-30$C$29.53 M112.84%
2019-06-30$C$13.87 M-40.26%
2018-06-30$C$23.22 M-12.01%
2017-06-30$C$26.39 M-11.61%
2016-06-30$C$29.86 M-24.69%
2015-06-30$C$39.65 M59.04%
2014-06-30$C$24.93 M196.14%
2013-06-30$C$8.42 M-40.29%
2012-06-30$C$14.1 M43.86%
2011-06-30$C$9.8 M42.04%
2010-06-30$C$6.9 M141.65%
2009-06-30$C$2.85 M531.82%
2008-06-30$C$0.45 M-14.77%
2007-06-30$C$0.53 M-61.43%
2006-06-30$C$1.37 M-1778.16%
2005-06-30$-C$0.09 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
BioCryst Pharmaceuticals
BCRX
-C$0.54 Billion-5,259.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-C$0.22 Billion-2,184.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$29.64 B 285,311.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$25.69 B 247,320.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$71.70 B 690,375.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$29.25 B 281,586.77%๐Ÿ‡ฌ๐Ÿ‡ง UK